BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  Magenta Therapeutics Hires John Davis, MD, MPH, as Chief Medical Officer

  Magenta Therapeutics, a biotechnology company developing therapeutics to improve and extend the use of curative bone marrow transplant for more patients, today announced that it has strengthened its clinical development team with the appointment of John Davis, MD, MPH, as chief medical officer.

  February 21, 2018

   · 

  3 min read
• Business

  Endologix Reports Fourth Quarter and Fiscal Year 2017 Financial Results

  Endologix, Inc. today announced financial results for the fourth quarter and fiscal year ended December 31, 2017.

  February 21, 2018

   · 

  15 min read
• Business

  Quidel Reports Fourth Quarter and Full Year 2017 Financial Results

  Quidel Corporation announced today financial results for the fourth quarter and year ended December 31, 2017.

  February 21, 2018

   · 

  19 min read
• Drug Development

  Vertex Initiates First Phase 3 Study of VX-659, Tezacaftor and Ivacaftor as a Triple Combination Regimen for People with Cystic Fibrosis

  Vertex Pharmaceuticals Incorporated is initiating the first Phase 3 study of VX-659, tezacaftor and ivacaftor as an investigational triple combination regimen for people with cystic fibrosis (CF) who have one F508del mutation and one minimal function mutation.

  February 21, 2018

   · 

  6 min read
• Business

  AAC Holdings, Inc. Reports Fourth Quarter and Full Year 2017 Results

  Today AAC Holdings, Inc. announced financial results for the fourth quarter and year ended December 31, 2017.

  February 21, 2018

   · 

  55 min read
• Business

  Arix Bioscience and Ipsen Sign a Strategic Agreement to Develop and Commercialise Innovative Therapies

  Arix Bioscience and Ipsen Sign a Strategic Agreement to Develop and Commercialize Innovative Therapies

  February 21, 2018

   · 

  7 min read
• Business

  10x Genomics Joins EMBL’s Corporate Partnership Program

  10X Genomics., a company focused on accelerating genomic discovery, today announced that it has joined the Corporate Partnership Program of the European Molecular Biology Laboratory.

  February 21, 2018

   · 

  3 min read
• Biotech Beach

  Evofem Biosciences Receives Fast Track Designation for Amphora for Prevention of Chlamydia

  Evofem Biosciences, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Amphora® vaginal gel for the prevention of urogenital chlamydia in women.

  February 21, 2018

   · 

  5 min read
• Business

  Bruker Announces Resignation of Chief Financial Officer

  Bruker Corporation announced that Mr. Anthony L. Mattacchione, Chief Financial Officer (CFO) and Senior Vice President of Bruker, has submitted his resignation, effective as of March 16, 2018.

  February 21, 2018

   · 

  3 min read
• Business

  Blueprint Medicines Reports Fourth Quarter and Full Year 2017 Financial Results

  Blueprint Medicines Corporation, a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today reported financial results and provided a business update for the fourth quarter and full year ended December 31, 2017.

  February 21, 2018

   · 

  20 min read